Back | Next |
home / stock / trib / trib message board
Subject | By | Source | When |
---|---|---|---|
Its better than 80 million release of new | HeilHiden | investorshub | 12/20/2021 2:50:47 PM |
Its a good deal to pay 8 million | StockLogistics | investorshub | 12/20/2021 2:21:07 PM |
600k a month | HeilHiden | investorshub | 12/20/2021 1:49:40 PM |
With over 100 million in revenues a year | HeilHiden | investorshub | 12/20/2021 1:47:29 PM |
Good deal all of it! | HeilHiden | investorshub | 12/20/2021 1:45:03 PM |
11% annual rate is more than 8 million | StockLogistics | investorshub | 12/20/2021 3:25:01 AM |
The Company and its subsidiaries entered into | StockLogistics | investorshub | 12/20/2021 3:24:01 AM |
Cant wait for Monday! | HeilHiden | investorshub | 12/18/2021 4:11:57 PM |
One buyer takes us up multiple cents. The | HeilHiden | investorshub | 12/17/2021 4:58:22 PM |
Current spread is 4 cents. 1.52 bid 1.56 ask | HeilHiden | investorshub | 12/17/2021 4:55:46 PM |
Ask is thin. Company restructuring debt for a | HeilHiden | investorshub | 12/17/2021 4:54:27 PM |
In connection with the Term Loan the Company | StockLogistics | investorshub | 12/17/2021 1:03:03 PM |
Saw it today! | HeilHiden | investorshub | 12/10/2021 3:08:45 PM |
The lower we go the more a buy | HeilHiden | investorshub | 12/08/2021 7:18:22 PM |
December 14 next chart opportunity imo, .68 cent | StockLogistics | investorshub | 12/06/2021 1:28:51 PM |
Value stock over perform during times of market | HeilHiden | investorshub | 11/29/2021 9:17:51 PM |
Its a value stock is why Im in | HeilHiden | investorshub | 11/29/2021 9:16:37 PM |
Six month consolidation ends today, should have news | StockLogistics | investorshub | 11/29/2021 1:02:26 PM |
There is a gap at .68 cents and | StockLogistics | investorshub | 11/29/2021 12:39:06 PM |
Lets rolllll | HeilHiden | investorshub | 11/26/2021 2:44:38 PM |
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...